Degradation of chromosomal DNA into nucleosomesized fragments is one of the characteristics of apoptotic cell death. Here, we examined whether caspase-activated DNase (CAD) is responsible for the DNA fragmentation that occurs upon exposure to various apoptotic stimuli. When human Jurkat cells were exposed to etoposide, or UV or g radiation, a caspase-3-like protease was activated, and nuclear DNA was fragmented. Human TF-1 cells, which are dependent on granulocyte-macrophage colony-stimulating factor (GM ± CSF), also underwent apoptosis accompanied by the activation of caspase-3-like protease and DNA fragmentation, when cultured without the cytokine. Both Jurkat and TF-1 cells expressed two forms of ICAD, ICAD-L and ICAD-S, which were cleaved upon exposure to these apoptotic stimuli. Among eight dierent caspases examined, recombinant caspases 3 and 7 speci®cally cleaved ICAD synthesized in a cell-free system. An expression plasmid containing mouse ICAD-L mutated at the caspase-3-recognition sites was then introduced into Jurkat and TF-1 cells. When the transformants were induced to undergo apoptosis (by treatment with etoposide, UV or g radiation for Jurkat cells, or factor withdrawal for TF-1 cells) they did not show DNA fragmentation, although they still died as a result of these stimuli. These results indicated that CAD, released from ICAD by caspase activation, is involved in the nuclear DNA fragmentation induced by these apoptotic stimuli.
Introduction
Apoptosis is a mechanism by which useless or pathological cells are deleted in all metazoans (Jacobson et al., 1997) . It is characterized by a set of morphological changes including membrane blebbing, cell shrinkage, nuclear condensation, and cleavage of nuclear DNA (Wyllie, 1980; Wyllie et al., 1980) . The execution of this cell death program is dependent on the caspases, a family of intracellular proteases with stringent substrate speci®city that are activated in response to diverse apoptotic stimuli (Cohen, 1997; Nicholson and Thornberry, 1997; Thornberry and Lazebnik, 1998 (Peitsch et al., 1993) , cyclophilins (Gaido and Cidlowski, 1991; Montague et al., 1994) and DNase g (Shiokawa et al., 1998) . DNase II, despite its acid pH dependence, was also proposed as the apoptotic nuclear DNase (Barry and Eastman, 1993) . However, the activation of these nucleases did not bear any clear relation to the signaling events responsible for the execution of the apoptotic program.
The link between caspase activation and nuclear DNA fragmentation was elucidated by the puri®cation and cloning of a caspase activated DNase (CAD) , also called CPAN and DFF-40 (Halenbeck et al., 1998; Liu et al., 1998) , and its inhibitor ICAD. The full-length form of mouse ICAD (ICAD-L) is a 45 kDa protein consisting of 331 amino acids. A short form (ICAD-S), consisting of amino acids 1 ± 261 of ICAD-L plus four C-terminal amino acids speci®c to ICAD-S, is also expressed in mouse lymphoma cells . ICAD-L is the mouse homologue of a previously de®ned caspasesubstrate linked to nuclear DNA degradation named 45 kDa DNA fragmentation factor (DFF-45), which was puri®ed and cloned from human HeLa cells (Liu et al., 1997) . CAD has intrinsic DNase activity, but in growing cells it exists as a complex with ICAD. Caspase-3-mediated cleavage of ICAD at amino acids Asp-117 and Asp-224 appears to dissociate the CAD:ICAD complex, allowing free CAD to cleave chromosomal DNA. ICAD speci®cally inhibits the DNase activity of CAD, but not that of DNase I or DNase II . Overexpression of ICAD in Jurkat cells inhibits staurosporine-or Fas-induced DNA fragmentation, implying that CAD is the DNase responsible for the nuclear DNA fragmentation induced by these stimuli .
However, the involvement of ICAD cleavage and CAD activation in the DNA fragmentation seen upon exposure to other apoptotic stimuli has not yet been investigated. In particular, treatments that directly damage cellular DNA could conceivably result in the activation of DNases other than CAD. Here we tested whether CAD is involved in DNA fragmentation in these cases. Human Jurkat cells were exposed to etoposide, or high doses of UV or g radiation, which damage DNA. These treatments activated a caspase-3-like protease, cleaved ICAD, and caused DNA fragmentation. When Jurkat cell transformants that express mouse ICAD-L bearing mutations at the caspase 3 cleavage sites were treated with these stimuli, no DNA fragmentation was observed, although the cells still died. To extend our work to another cell type and to another mode of apoptosis induction, granulocyte-macrophage colony-stimulating factor (GM ± CSF)-dependent human erythroleukemia TF-1 cells (Kitamura et al., 1989) were used as a model for growth factor withdrawal-induced apoptosis. In this model, ICAD was cleaved during apoptotic cell death, and overexpression of the non-cleavable ICAD mutant prevented DNA fragmentation. These results indicated that CAD is responsible for the DNA fragmentation resulting from a variety of apoptotic stimuli.
Results

DNA fragmentation and cleavage of ICAD in response to DNA damaging agents
High doses of UV radiation are known to produce two major types of DNA damage: cyclobutane pyrimidine dimers and 6-4 photoproducts. Etoposide, an inhibitor of topoisomerase II, and high doses of g radiation cause double-strand breaks in chromosomal DNA. To examine whether CAD is responsible for the DNA fragmentation induced by these apoptotic stimuli, Jurkat cells were exposed to UV radiation (300 J/m 2 ), etoposide (30 mM), or g radiation (100 Gy). As reported previously (Clarke et al., 1993) , all these agents caused DNA fragmentation (Figure 1 ). UV radiation was the most eective treatment and extensive DNA fragmentation was observed as early as 2 h afterwards. On the other hand, it took more than 4 ± 6 h for DNA fragmentation to occur following etoposide or g radiation treatment under our experimental conditions.
If CAD is implicated in DNA fragmentation, then ICAD should be cleaved in apoptotic cells. To investigate this possibility, ICAD in cytoplasmic extracts from Jurkat cells treated with etoposide, UV or g radiation was examined by Western blotting using a monoclonal antibody speci®c for human ICAD as the probe. This monoclonal antibody binds to a Cterminal epitope of ICAD found between amino acids 225 ± 261 (D McIlroy and S Nagata unpublished observation). As shown in Figure 1b , the antibody bound to two bands, proteins of 45 and 37 kD, in the cytosolic extracts from non-apoptotic Jurkat cells. Two forms of mouse ICAD cDNA, coding for proteins consisting of 331 and 265 amino acids, respectively are generated by the alternative use of a poly(A) adenylation signal in intron 5 (K Kawane and S Nagata, unpublished results). The two bands recognized by the anti-human ICAD antibody indicate High-dose UV treatment of Jurkat cells resulted in the extensive cleavage of both ICAD-L and ICAD-S within 1 h. At this time the major detectable ICAD cleavage product was the 12 kDa fragment. Human DFF-45/ICAD has two putative recognition sites for caspase-3, at Asp-117 and Asp-224 (Liu et al., 1997; and see below) . The 12 kDa fragment is probably the product of ICAD-L cleaved at Asp-224 (the calculated M r for this fragment is 11.7 kDa). ICAD fragments generated by caspase cleavage of ICAD-L and ICAD-S at Asp-117, migrating at 28 kDa and 19.5 kDa respectively, were detected as early as 30 min after UV radiation. The detection of these bands preceding the appearance of the 12 kDa fragment suggests that ICAD is ®rst cleaved at Asp-117, and then at Asp-224. The level of general proteolysis in UV-irradiated cells, indicated by a-tubulin staining, remained low for 8 h, after which extensive non-speci®c protein cleavage was observed ( Figure 1b) .
A similar pattern of ICAD cleavage was seen in Jurkat cells after treatment with etoposide or g radiation, although the kinetics were slower than that observed with UV irradiation. Complete cleavage of ICAD was eventually observed after 8 h of etoposide treatment, whereas g radiation only partially cleaved ICAD, even after 18 h. The extent of ICAD cleavage induced by UV irradiation, etoposide treatment, and g irradiation correlated well with the levels of DNA fragmentation caused by these agents (Figure 1 ).
Cleavage of ICAD by caspases 3 and 7, and the eect of a non-cleavable ICAD mutant on the DNA fragmentation induced by DNA damaging agents
The tetrapeptide sequences (DETD and DAVD) of human ICAD/DFF-45 at the amino acid positions 117 and 224 agree well with the preferred recognition site for caspases 2, 3 and 7 (Talanian et al., 1997a; Thornberry et al., 1997) , and human caspase-3 can cleave recombinant human and mouse ICAD at these positions (Liu et al., 1997; Sakahira et al., 1998) . To examine whether other caspases could cleave human ICAD, 35 S-labeled human ICAD was synthesized in vitro using a transcription-translation coupled system. Eight dierent mature recombinant caspases (caspases 1 ± 8) were produced in E. coli, and the ability of each to cleave human ICAD was analysed. As shown in ) of human ICAD was observed with the other caspases (caspases 1, 2, 4, 5, 6 and 8). These results indicated that caspase-3 and/or caspase 7 is responsible for the cleavage of ICAD, and thus for the activation of CAD in vivo. In fact, the cleavage of ICAD was accompanied by the gradual accumulation of caspase-3-like protease activity in the cytosolic fraction of cells undergoing apoptosis by these DNA damaging agents (Figure 2 ). The kinetics and extent of activation of caspase-3-like protease were similar to those for ICAD cleavage, and these processes were accompanied by apoptotic cell death, as assayed by Annexin V-staining ( Figure 2) .
To con®rm the involvement of ICAD cleavage by caspase in the DNA fragmentation induced by DNA damaging agents, Jurkat cell transformants (JILdm) expressing FLAG-tagged mouse ICAD carrying the Asp to Glu mutation at positions 117 and 224, were established. When these transformants were exposed to UV radiation, etoposide, or g radiation, the activation of caspase-3-like protease as well as cleavage of the endogenous human ICAD were observed with similar kinetics as in the parental Jurkat cells (Figure 3a and data not shown). However, the exogenously introduced mouse ICAD mutant, detected by anti-FLAG antibody, remained intact until the cells underwent nonspeci®c proteolysis at a later stage of cell death. Chromosomal DNA was not fragmented in JILdm cells after treatment with these genotoxic reagents (Figure 3b) , even though the number of Annexin Vpositive cells increased (Figure 3c ). DNA recovered from cells decreased at later time points (after 24 h), in particular after etoposide treatment.
Involvement of CAD/ICAD in factor deprivation-induced DNA fragmentation
The involvement of CAD in another type of apoptotic DNA fragmentation, which occurs upon factor deprivation, was examined with human erythroleukemia TF-1 cells. Human TF-1 cells require cytokines such as GM ± CSF, G-CSF, IL-3, or erythropoietin for their survival (Kitamura et al., 1989) . When TF-1 cells were starved for human GM ± CSF, they underwent apoptosis, which was accompanied by DNA fragmentation (Figure 4 ). Apoptotic cell death and DNA fragmentation were preceded by a lag time of at least 12 h, during which caspase 3 activity increased modestly and only partial ICAD cleavage could be detected. In contrast to g-irradiated Jurkat cells, this level of caspase-3 activity and ICAD cleavage was not sucient to induce cell death or DNA fragmentation in TF-1 cells. After 24 h, caspase-3-like protease activity rose to very high levels resulting in complete cleavage of ICAD, which corresponded with the start of DNA fragmentation. To con®rm the involvement of ICAD in the factor deprivation-induced DNA fragmentation, the TF-1 cells were transformed with FLAG-tagged mouse ICAD-L containing the mutations D117E and D224E, to produce TILdm cell lines. As shown in Various recombinant human caspases were prepared in E. coli, puri®ed to homogeneity, and their activity to cleave 35 S-labeled ICAD was determined as described in Material and methods. The PARP cleavage activity of capsases 3 and 7 are also shown. n.d., not determined 
Discussion
Several apoptotic pathways have been elucidated so far (Ra, 1998) . In one pathway, triggered by death factors such as Fas ligand, TNF, and Apo3 ligand, caspase 8 is activated by receptor aggregation at the plasma membrane, which leads to the activation of other, downstream caspases (Ashkenazi and Dixit, 1998; Nagata, 1997) . The second pathway, triggered by DNA-damaging agents such as g radiation and anticancer drugs, contains a step that is dependent on the p53 tumor suppressor gene product (Clarke et al., 1993; Evan and Littlewood, 1998) . Although it is not clear how p53 is involved in this process, this pathway stimulates the release of cytochrome C from mitochondria, which activates caspase 9 together with Apaf-1 (Green and Reed, 1998) . Once caspase 9 is activated, it then promotes apoptosis by activating downstream caspases. The third apoptotic pathway is triggered by the deprivation of survival factors from factordependent cells. In this case, deprivation of the survival factors causes the dephosphorylation of Bad, a pro-apoptotic member of the Bcl-2 family, and engages the death pathway probably acting through mitochondria (Ra, 1998) . All these apoptotic pathways culminate in the degradation of chromosomal DNA into nucleosomal units. Previously, we have shown that the Fas-induced apoptotic signal eventually activates a DNase (CAD), via cleavage of its inhibitor, ICAD Sakahira et al., 1998) . In this report, we showed that other apoptotic stimuli, DNA damaging agents and factor deprivation, also caused the degradation of ICAD, and non-cleavable ICAD mutants inhibited the DNA fragmentation induced by these stimuli. Since ICAD speci®cally inhibits CAD's DNase activity, but not that of DNase I or DNase II , these results indicate that CAD, or at least an ICAD-inhibitable DNase(s), is responsible for the DNA fragmentation caused by most, if not all, apoptotic stimuli. However, it should be noted that a small amount of DNA fragmentation was seen in JILdm cells after 24 h of etoposide treatment, which implies that a DNase(s) other than CAD may mediate some chromosomal DNA fragmentation in the later stages of apoptotic cell death. At this time point, cell disintegration was at an advanced stage and nonspeci®c proteolysis was extensive, so it is possible that Caspase-3-like activity in cytoplasmic lysate (5 mg protein) was measured by detecting cleavage of the¯uorogenic substrate MCA-DEVDAPK(dnp) at 1 mM in ICE standard buer for 1 h at 308C. Fluorescence emission at 392 nm was measured, and speci®c uorescence units per mg protein were calculated by subtracting the¯uorescence observed after cleavage of substrate MCA-DEVDAPK(dnp) in the presence of the caspase-3 inhibitor Ac-DEVD-cho (6 mM). (b) The percentage of apoptotic cells with phosphatidyl serine exposed on the cell surface was assessed by binding of the FITC-Annexin V lysosomal DNase II could have gained access to chromosomal DNA. Most apoptotic stimuli eventually activate caspase-3-like protease(s). Among 8 recombinant caspases examined, caspases 3 and 7 eciently cleaved ICAD with similar k cat /K m values. Unlike the recent publication suggesting that caspase-7 cleaves ICAD at Asp-117, while caspase-3 cleaves ICAD at Asp-224 (Tang and Kidd, 1998) , both recombinant caspases 3 and 7 eciently cleaved both Asp-117 and Asp-224 sites in ICAD (unpublished observation), indicating that either caspase-3 or caspase-7 can activate CAD to cause the DNA fragmentation. On the other hand, a cell line (MCF-7) lacking caspase-3, and thymocytes and splenocytes from caspase-3-null mice do not show DNA fragmentation upon treatment with apoptotic stimuli (Janicke et al., 1998; Tang and Kidd, 1998; Woo et al., 1998) . Recent analysis of the subcellular localization of caspase-3 and caspase-7 has indicated that the active caspase-3 is primarily localized in the cytosol, whereas active caspase-7 is in the microsomal and mitochondria fractions (Chandler et al., 1998) . This dierent subcellular distribution of caspases 3 and 7 may explain why the cells lacking caspase-3 do not undergo DNA fragmentation after apoptotic stimuli.
Expression of mICADLdm did not reduce the susceptibility of JILdm or TILdm cells to apoptotic stimuli, since the kinetics of the appearance of apoptotic JILdm or TILdm cells was identical to that of parental Jurkat or TF-1 cells. Hence, as with apoptosis induced by Fas ligation , nuclear DNA fragmentation was not a prerequisite for cell death. In addition, transfected mICADLdm did not block caspase-3 activation or cleavage of endogenous human Rather, we conclude that mICADLdm expressed in JILdm and TILdm cells was able to bind to active CAD freed from endogenous CAD:ICAD complexes sufficiently quickly to prevent nuclear DNA fragmentation. CAD normally exists complexed with ICAD, and it had not been formally ruled out that the cleaved product of ICAD is necessary for DNA degradation, or that it works as a pro-apoptotic molecule (Liu et al., 1997) , as found with Bcl-2 or Bcl-x L . Here, in JILdm and TILdm cells, the endogenous ICAD was cleaved by the apoptotic stimuli, yet the cells did not show DNA fragmentation, indicating that the cleaved product of ICAD has no active role in DNA fragmentation. This ®nding agrees with recent results that homogeneously puri®ed recombinant CAD eciently causes DNA fragmentation in nuclei and digests DNA (Halenbeck et al., 1998 , and H Sakahira and S Nagata, unpublished observation). The DNA fragmentation induced by all the apoptotic stimuli investigated in this report was accompanied by the activation of caspase-3-like protease and cleavage of ICAD. However, caspase activation does not necessarily lead to DNA fragmentation (Ishizaki et al., 1998) . Whether any caspaseresistant molecules inhibit CAD's DNase activity, remains to be studied.
Materials and methods
Cell lines
Human Jurkat cells were maintained in RPMI medium supplemented with 10% fetal calf serum (FCS, Gibco/BRL).
The human TF-1 cell line (Kitamura et al., 1989) was provided by Dr T Kitamura (Institute of Medical Science, University of Tokyo) and was maintained in RPMI medium containing 10% FCS and 5 ng/ml human GM ± CSF (provided by Schering-Plough Pharmaceutical Co.).
Transformation
The mouse ICAD cDNA in which the codons for Asp-117 and Asp-224 were mutated to those for Glu was described previously . A DNA fragment coding for the FLAG epitope was joined to the 5'-end of the coding sequence of the mutated ICAD, and placed under the human EF-1a promoter in the pEF-BOS vector to generate pEF-FLAG-ICAD-Ldm.
Transformation of Jurkat and TF-1 cells was carried out by electroporation as described previously . In brief, 5610 6 cells were suspended in 400 ml potassium phosphate-buered saline (K-PBS) containing 5 mM Mg 2+ , 50 mg ApaLI-digested pEF-FLAG-ICAD-Ldm, and 5 mg XhoI-digested pBLIIhyg for Jurkat cells or pSTNeo for TF-1 cells. After electroporation at 280 V with a capacitance of 960 mF, the cells were resuspended in 25 ml of the medium. After culturing for 30 h, antibiotics (hygromycin B for Jurkat, or G-418 for TF-1) were added to the cells at a concentration of 0.8 mg/ml or 0.6 mg/ml, respectively, which were then cultured in 48-well plates. The hygromycin B or G-418-resistant clones were screened for expression of FLAGtagged ICAD-L by Western blotting using the anti-FLAG M2 mAb (Kodak), and the positive clones were termed JILdm' for the Jurkat transformants, and`TILdm' for the TF-1 transformants.
Induction and assay of apoptosis
Jurkat and JILdm cells were resuspended at 5610 5 cells/ml in RPMI1640 medium containing 10% FCS, then apoptosis was induced by the addition of etoposide to 30 mM. For UV or g radiation, cells were transferred to Petri dishes, then exposed to 300 J/m 2 short wavelength (254 nm) UV radiation in a Stratalinker UV oven (Stratagene), or to g radiation with a Cs 137 source emitting at 1.2 Gy/min using a Gammacell 40 Exactor (Nordion International Inc.). For growth-factorwithdrawal experiments, TF-1 and TILdm cells were washed three times with RPMI medium containing 10% FCS, then resuspended at 2.5610 5 cells/ml in the same medium. After each apoptosis-inducing treatment, cells were incubated for dierent periods of time at 378C. In all cases, T=0 was taken as the moment when cells were placed in the incubator after apoptosis induction.
Apoptotic cells were quanti®ed by FITC-conjugated Annexin V binding and propidium iodide staining using the Apoptosis Detection Kit (R&D Systems) according to the manufacturer's instructions. DNA fragmentation was assessed essentially as described previously (Itoh et al., 1991) . Brie¯y, cells were lysed in DNA lysis buer (100 mM Tris HCl, pH 8.5, 5 mM EDTA, 0.2% SDS, 200 mM NaCl, 200 mg/ml Proteinase K), and incubated overnight at 378C. Nucleic acids were precipitated with an equal volume of isopropanol, resuspended in 10 mM Tris-HCl buer (pH 7.5) containing 1 mM EDTA and 200 mg/ml RNase A, and incubated at 378C for 1 h.
Assay for caspase
Caspase 3-like activity in cytoplasmic lysates was assayed as described previously (Enari et al., 1996) . 2610 6 cells were suspended in 50 ml EP buer (50 mM PIPES pH 7.0, 50 mM KCl, 5 mM EGTA, 2 mM MgCl 2 , 1 mM DTT, 1 mM PMSF, 20 mM cytochalasin B, 1 mg/ml leupeptin, 1 mg/ml pepstatin A, 50 mg/ml antipain, 10 mg/ml chymostatin) then lysed by repeated freezing-thawing ®ve times. Lysates were cleared by centrifugation for 15 min at 50 000 r.p.m., and the supernatant fractions were collected. Aliquots (5 mg) were diluted in 300 ml of ICE standard buer (100 mM HEPES pH 7.5, 10% sucrose, 0.1% CHAPS, 1 mM DTT, 100 mg/ml ovalbumin) either with or without 10 mM Ac-DEVD-CHO (Peptide Institute, Osaka, Japan), and incubated for 30 min on ice. Two-hundred microliters of ICE standard buer containing 2.5 mM MCA-DEVDAPK(dnp) (Peptide Institute) was then added, and the samples were incubated at 308C for 1 h. Cleavage of the substrate peptide was measured using a Shimadzu RF-1500 UV spectro¯uorometer set at an excitation wavelength of 325 nm and an emission wavelength of 392 nm.
Western blotting
For Western blotting, the cytosolic fractions were fractionated on 10 ± 20% or 15 ± 25% gradient polyacrylamide gels, then transferred onto a Hybond P PVDF membrane (Amersham-Pharmacia) for 1 h at 160 mA using a semi-dry transfer system. Membranes were blocked by incubation in PBS-T (PBS supplemented with 0.05% Tween 20) containing 10% skim milk, overnight at 48C or for 3 h at room temperature. The ®lters were then incubated for 1 h at room temperature with mouse monoclonal antibody against human DFF-45 (ICAD) (0.1 mg/ml, clone 6B8, MBL), FLAG (1.0 mg/ml, clone M2, Kodak), or a-tubulin (0.5 mg/ml, clone AB-1, Oncogene Science) in PBS-T containing 5% skim milk. Membranes were washed three times in PBS-T, then incubated with horseradish peroxidase-conjugated goat antimouse IgG (DAKO) diluted 1 : 1000 in PBS-T containing 25% (v/v) Block Ace (Dainippon Seiyaku), for 1 h at room temperature. The proteins recognized by antibodies were visualized by chemiluminescence using the Renaissance kit (New England Nuclear).
Cleavage of ICAD by caspases
Recombinant caspases 1 ± 8 were produced in E. coli, and puri®ed as described (Kamens et al., 1995) . The assay for cleavage of human ICAD by various caspases was carried out essentially as described previously (Talanian et al., 1997b) . In brief, human ICAD and poly(ADP-ribose) polymerase (PARP) cDNAs were placed under the control of T7 RNA polymerase, and 35 S-Methionine-labeled proteins were synthesized using a TNT in vitro transcription/translation kit (Promega) according to the manufacturer's instructions. Seventy-®ve microliters of the TNT reaction mixture were supplemented with the reaction buer (100 mM HEPES-HCl, pH 7.5, 20% glycerol, 0.5 mM EDTA, 5 mM DTT) containing puri®ed caspase to a ®nal concentration of 10 ± 1000 nM. After incubation at room temperature for various periods of time (0 ± 30 min), 10-ml aliquots were removed, mixed with 75 ml of Laemmli's sample buer, and heated at 908C for 5 min. Aliquots (7.5 ml) were separated by SDS ± PAGE using 10 ± 20% Tris-tricine gels (Integration Separation Systems). Dried gels were imaged, and the band corresponding to ICAD was quanti®ed using a GS-250 Molecular Imager and Molecular Imaging Screen CS (BioRad). Apparent V max /K m values were obtained by plotting substrate band intensity versus time and ®tting the resulting data to an exponential decay curve (where k obs =V max /K m ), as described previously (Talanian et al., 1997a) . The k cat /K m values were then obtained by dividing k obs by enzyme concentration.
